🧫
experiment

Higher midlife p-tau181 levels were associated with increased risk of incident all-cause dementia (HR 1.15 per SD higher).

🧫 Experiment Protocol ClinicalAlzheimer's diseasehumanextracted
Plasma biomarkers measured using Quanterix Simoa platform from stored specimens; p-tau181 = phosphorylated tau at threonine 181
PRIMARY OUTCOME
Higher midlife p-tau181 levels were associated with increased risk of incident all-cause dementia (HR 1.15 per SD higher).
LINKED HYPOTHESES
Source: pmid_39068543
🧫 Experiment Extras
PATHWAY
tau phosphorylation pathway
MARKET PRICE
$0.50
STATUS
extracted
View on SciDEX ↗